Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000205297 | SCV000259694 | likely benign | Multiple endocrine neoplasia, type 2 | 2024-12-12 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000251081 | SCV000313733 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Ambry Genetics | RCV000574221 | SCV000674791 | likely benign | Hereditary cancer-predisposing syndrome | 2016-03-07 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
KCCC/NGS Laboratory, |
RCV003316129 | SCV004017354 | likely benign | Multiple endocrine neoplasia type 2B | 2023-07-07 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV000205297 | SCV005430311 | likely benign | Multiple endocrine neoplasia, type 2 | 2024-09-23 | criteria provided, single submitter | clinical testing |